Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.

2022 Startups to Watch
stats here
Related Posts on Startland News
Why the Savannah Bananas founder is coming back to KC (with a tip of his hat to winning leadership styles)
Jesse Cole isn’t afraid to reimagine the way things are done in business, he shared, and his brand of Banana Ball is paying off. In the past nine years, the ringleader of the Savannah Bananas — baseball’s answer to the trick ball-handling and exhibition athleticism of the Harlem Globetrotters — has gone from selling his…
‘Never settle’: He started small, now Drue Stewart is bringing TikTok-famous food to former Westport Ale House
‘Bigger, better, crazier; Never settle; The building had a dark cloud but we are going to bring new life to it’ Less than a year after opening Holy Brunch KC in Westport — and one small expansion — Drue Stewart is making an enormous leap. He’ll go from 2,000-square-feet on one floor, to a 16,000-square-foot…
Great Jobs KC leaps closer to its $100M goal with massive grant to support adult financial stability
A just-announced $60 million investment by the Ewing Marion Kauffman Foundation marks a significant step in a Kansas City-based nonprofit’s plans to support 50,000 adults on their journeys toward financial stability, said Earl Martin Phalen. The grant to Great Jobs KC serves three priorities outlined within the Kauffman Foundation’s new grantmaking strategy: college access and…
Teens tackle universal pain points: Junior Achievement competition pushes students to pitch biz ideas
A new student innovation competition linked to Junior Achievement not only challenges Kansas City teens to develop business solutions for immediate real-world problems, said Will Bowler; fostering entrepreneurial thinking develops longer-term impacts. “This program empowers them,” said Bowler, a teacher at Olathe East High School, as students wrapped up Tuesday’s 3DE Innovators Showcase at the…

